Multicentre validation study of nucleic acids extraction from FFPE tissues.
Author(s): Bonin S, Hlubek F, Benhattar J, Denkert C, Dietel M, Fernandez PL, Höfler G, Kothmaier H, Kruslin B, Mazzanti CM, Perren A, Popper H, Scarpa A, Soares P, Stanta G, Groenen PJ
Publication: Virchows Arch, 2010, Vol. 457, Page 309-17
PubMed ID: 20665046 PubMed Review Paper? No
Purpose of Paper
Conclusion of Paper
Studies
-
Study Purpose
The purpose of this study was to determine the effects of RNA and DNA extraction methods on the amplification of colorectal, lung, and ovary FFPE tumor specimens.
Summary of Findings:
The highest DNA yield was obtained when no further purification steps were taken after the initial DNA extraction. There was no correlation between extraction method and PCR success. The lung tissue allowed for amplification of a 300 bp product, regardless of extraction method, and a 400 bp product was amplifiable in some cases, but the largest amplification product from ovary and colon tissue was 200 bp. The highest quality RNA was from specimens purified using silica based column purification and was especially good using the Qiagen RNeasy FFPE kit, but quality depended on the user. The quality of the RNA did not predict amplification success, regardless of purification method.
Biospecimens
Preservative Types
- Formalin
Diagnoses:
- Neoplastic - Carcinoma
Platform:
Analyte Technology Platform DNA PCR RNA RT-PCR Pre-analytical Factors:
Classification Pre-analytical Factor Value(s) Analyte Extraction and Purification Analyte isolation method DNA extraction kit with precipitation step
DNA extraction kit without prrecipitation step
DNA extraction kit with silica columns
RNA extraction with homemade phenol-chloroform protocol
RNA extraction with phenol-chloroform based kit
RNA extraction with silica based column purification
Biospecimen Acquisition Biospecimen location Lung
Ovary
Colon
PCR Specific Length of gene fragment 100 bp
200 bp
300 bp
400 bp
RT-PCR Specific Length of gene fragment 103 bp
150 bp
200 bp
250 bp
RT-PCR Specific Targeted nucleic acid B-actin
PBGD
B2M
PCR Specific Targeted nucleic acid BIOMED